glp-1 biosimilar Drugs Market Size to Hit USD 132.79 Bn by 2035 Biocon's Biosimilar Push Faces Fierce

Sheets C, Peden M, Guy J

GLP-1 medications like semaglutide and tirzepatide have changed weight-loss conversation

REGALO Consigue tu libro electrnico gratuito con 7 pequeos hbitos que te ayudarn a llevar una vida ms sana y feliz

Conformationally Stabilized Mimetics

Then in an announcement on Tuesday, the drugmaker unveiled that the National Medical Products Administration (NMPA), Chinas top drug regulator, had allowed the injection to be used in weight reduction, making it the first GLP-1 receptor agonist officially available in the country for people who wish to lose weight but for diabetes-unrelated reasons

Eligibility under TA875 requires the presence of at least one weight-related comorbidity and a BMI of 35 kg/m or above